Categories Finance, U.S. Markets News

Federal Reserve likely to lift rates by a quarter point

The Federal Reserve is widely expected to lift the key borrowing rate for the fourth time this year by a quarter point at its decision today. This is in spite of the pressure from President Donald Trump and members of his administration.

The interest rates are likely to be raised by 0.25 point to 2.50%. The decision could impact all kinds of borrowing rates from home mortgages to credit cards. The Fed last lifted rates in September and the economy has given off mixed signals. But the stock market has dropped in recent months due to the ongoing trade tensions between the US and China.

Traders will be looking closely on the bank’s accompanying statement and guidance for the suggestion about future rate hikes. The major index futures remained higher after the major averages ended Tuesday’s trading on a positive note. The markets remained confident that the bank will strike a dovish tone in its decision.

Meanwhile, the president urged the central bank to abstain from lifting rates at the current slow pace. Trump has shared his complaints about the Fed through the Twitter social platform. In addition, in an interview with Fox Business in October, the president called the bank his greatest threat and made Fed chairman Jerome Powell for pointed attacks.

The Fed is unlikely to bow down to political pressure. However, the bank could consider the president’s suggestion and signal rates hike at a much slower pace than the current one. This is due to the weak economic data, low inflation, and trade dispute concerns.

Meanwhile, the markets expect the Fed to signal two rate hikes instead of the three. This will help in stabilizing the stocks and keeping the 10-year treasury yield below 4%.

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top